Literature DB >> 18242653

Modulation of Abeta-induced neurotoxicity by estrogen receptor alpha and other associated proteins in lipid rafts.

Raquel Marin1, Cristina Ramírez, Araceli Morales, Miriam González, Rafael Alonso, Mario Díaz.   

Abstract

Some evidences have demonstrated the participation of estrogen receptors (ERs) in rapid, non-genomic actions of estrogen to promote neuroprotection against different toxic agents. However, there is still very little information about the structural nature of these receptors and the manner these proteins may be integrated into the plasma membrane. One of the plausible possibilities is that they may be localized in lipid rafts microstructures where they would be associated with other, still unknown, molecules which may modulate their physiological activities related to cell survival. In this work, we have identified in caveolar fractions of murine septal and hippocampal neurons a membrane-related ER shown to physically interact with, both, a voltage-dependent anion channel and scaffold protein caveolin-1.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18242653     DOI: 10.1016/j.steroids.2007.12.007

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  10 in total

Review 1.  Neuroprotective actions of estradiol and novel estrogen analogs in ischemia: translational implications.

Authors:  Anne M Etgen; Teresa Jover-Mengual; R Suzanne Zukin
Journal:  Front Neuroendocrinol       Date:  2010-12-14       Impact factor: 8.606

2.  Estrogen- and xenoestrogen-induced ERK signaling in pituitary tumor cells involves estrogen receptor-α interactions with G protein-αi and caveolin I.

Authors:  Cheryl S Watson; Yow-Jiun Jeng; Guangzhen Hu; Ann Wozniak; Nataliya Bulayeva; Jutatip Guptarak
Journal:  Steroids       Date:  2011-12-30       Impact factor: 2.668

3.  Neuronal ER-Signalosome Proteins as Early Biomarkers in Prodromal Alzheimer's Disease Independent of Amyloid-β Production and Tau Phosphorylation.

Authors:  Fátima Mesa-Herrera; Raquel Marín; Eduardo Torrealba; Guido Santos; Mario Díaz
Journal:  Front Mol Neurosci       Date:  2022-05-05       Impact factor: 6.261

4.  Neuroprotective actions of selective estrogen receptor modulators.

Authors:  Lydia L DonCarlos; Iñigo Azcoitia; Luis M Garcia-Segura
Journal:  Psychoneuroendocrinology       Date:  2009-12       Impact factor: 4.905

5.  Signalosomes in the brain: relevance in the development of certain neuropathologies such as Alzheimer's disease.

Authors:  Raquel Marin
Journal:  Front Physiol       Date:  2011-06-03       Impact factor: 4.566

6.  Plasmalemmal VDAC-1 corroborated as amyloid Aß-receptor.

Authors:  Friedrich P Thinnes
Journal:  Front Aging Neurosci       Date:  2015-09-30       Impact factor: 5.750

7.  Effects of Dietary n-3 LCPUFA Supplementation on the Hippocampus of Aging Female Mice: Impact on Memory, Lipid Raft-Associated Glutamatergic Receptors and Neuroinflammation.

Authors:  Lucas Taoro-González; Daniel Pereda; Catalina Valdés-Baizabal; Miriam González-Gómez; José A Pérez; Fátima Mesa-Herrera; Ana Canerina-Amaro; Herminia Pérez-González; Covadonga Rodríguez; Mario Díaz; Raquel Marin
Journal:  Int J Mol Sci       Date:  2022-07-04       Impact factor: 6.208

Review 8.  Estrogen Interactions With Lipid Rafts Related to Neuroprotection. Impact of Brain Ageing and Menopause.

Authors:  Raquel Marin; Mario Diaz
Journal:  Front Neurosci       Date:  2018-03-06       Impact factor: 4.677

9.  C-Cbl reverses HER2-mediated tamoxifen resistance in human breast cancer cells.

Authors:  Wei Li; Ling Xu; Xiaofang Che; Haizhou Li; Ye Zhang; Na Song; Ti Wen; Kezuo Hou; Yi Yang; Lu Zhou; Xing Xin; Lu Xu; Xue Zeng; Sha Shi; Yunpeng Liu; Xiujuan Qu; Yuee Teng
Journal:  BMC Cancer       Date:  2018-05-02       Impact factor: 4.430

Review 10.  The Critical Period for Neuroprotection by Estrogen Replacement Therapy and the Potential Underlying Mechanisms.

Authors:  Hang Guo; Min Liu; Lixia Zhang; Long Wang; Wugang Hou; Yaqun Ma; Yulong Ma
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.